A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults

J. Alfa, Michelle; Strang, David; S. Tappia, Paramjit; Olson, Nancy; DeGagné, Pat; A. Bray, David; Murray, Brenda-Lee; Hiebert, Brett

doi:10.3389/fmed.2017.00260

Public

A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults

Published in Frontiers in Medicine • Jan 22, 2018

Authors:

Michelle J. Alfa

David Strang

Paramjit S. Tappia

Abstract

Introduction: Type 2 Diabetes (T2D) has reached epidemic proportions in North America. Recent evidence suggests that prebiotics can modulate the gut microbiome, which then plays an important role in regulating lipid metabolism, blood glucose, and insulin sensitivity. As such, prebiotics are appealin...

Subject

Insulin resistance

Insulin

Digestion (alchemy)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!